Guangzhou Echom Sci&Tech Co Ltd (002420) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Guangzhou Echom Sci&Tech Co Ltd ¥3.46, price ¥6.08, upside -43.1%, quality 51 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Guangzhou Echom Sci&Tech Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ¥3.08 – ¥11.10 · fair‑value band ¥2.62 – ¥4.51 · the ¥6.08 price screens above the ¥3.46 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.
Follow Guangzhou Echom Sci&Tech Co in your weekly email
Every Wednesday you see whether Guangzhou Echom Sci&Tech Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Guangzhou Echom Sci.&Tech.Co.,Ltd engages in the design, production, and sales of television, white appliance, and automobile structural parts in China and internationally. The company offers interior and exterior, thermal management, and lightweight products; and energy storage system structural components.
Show more
Guangzhou Echom Sci.&Tech.Co.,Ltd engages in the design, production, and sales of television, white appliance, and automobile structural parts in China and internationally. The company offers interior and exterior, thermal management, and lightweight products; and energy storage system structural components. It also provides healthcare products, including reaction cups, deep hole plates, PCR tubes/plates, virus sampling tubes, microcentrifuge tubes, centrifuge tubes, serum pipettes, serum square bottles, cryopreservation tubes, and cell culture plate, dishes, and flasks, as well as Erlenmeyer flasks. Further, the company offers multi-cavity consumable mold antigen test card bottom cover automated pipette tips, 96 deep hole plate, immune response cup, and quantitative pipette; and robot parts. Guangzhou Echom Sci.&Tech.Co.,Ltd was founded in 1997 and is headquartered in Guangzhou, China.
Stock analysis
Guangzhou Echom Sci&Tech Co Ltd (002420) currently trades at ¥6.08, while our model-based Fair Value estimate is ¥3.46, implying the stock looks roughly 75.7% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥8.59 per share, and 6 of the 17 models we run sit above the ¥6.08 price.
Bear case: the Dividend Discount group reads lowest at ¥0.3800, and 11 of the 17 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥2.62 (bear) to ¥4.51 (bull), the price of ¥6.08 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Technology sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Guangzhou Echom Sci&Tech Co Ltd reported revenue of 3.0B CNY in FY2025 versus 3.7B CNY in FY2021, a compound −5.6%/yr. Reported net income was 191M CNY in FY2025, compounding +26.7%/yr from FY2021.
Key figures
Market cap 2.5B CNY (≈ $373M) · P/E ratio 12.9 · P/S ratio 0.83 · EPS (TTM) ¥0.4700 · Dividend yield 0.6% · Net margin 6.4% · Return on equity 28.1% · Return on assets (EBIT) 1.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 31% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −37% fair-value upside, at −43%, 002420 screens richer than that median.
Fair Value models
Bear ¥2.62Fair Value ¥3.46Bull ¥4.51
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.3451 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.28/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+10.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.6%
Start year 2020 (pandemic). Over 10 years: −2.2% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +2.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.9%
Dividend (yield on the price)0.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.20% vs 16%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 3%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 2.1%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Rate on operating basis: 2025 sits 174% above its own trend.
Compare Guangzhou Echom Sci&Tech Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Consumer Electronics · 128 stocks
Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score51 · Below median
Fair Value upside−44% · Below median
Profitability
Return on equity (TTM)28% · Top 25%
Return on assets1% · Above median
Net margin (TTM)7% · Top 25%
Operating margin (TTM)6% · Above median
Growth and dividend
Revenue growth−18% · Bottom 25%
Dividend yield (TTM)0.6% · Bottom 25%
Balance sheet
Debt / equity0.09× · Above median
Valuation Multiplesvs Consumer Electronics median · lower = cheaper
P/E (TTM)12.9× · Cheapest 25%
P/B3.27× · Priciest 25%
P/S (TTM)0.89× · Pricier than median
EV/EBITDA19.6× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 9
FUTURE (revenue growth)0· sector 6
PAST (return on equity)100· sector 18
HEALTH (low debt)96· sector 97
DIVIDEND (yield)12· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Guangzhou Echom Sci&Tech Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/002420
Frequently asked questions
Is Guangzhou Echom Sci&Tech Co Ltd (002420) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥3.46 versus a price of ¥6.08, about −43% upside (overvalued).
What is the fair value of 002420?
Our model-based fair value for Guangzhou Echom Sci&Tech Co Ltd is ¥3.46 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥6.08.
What is the quality score of 002420?
Guangzhou Echom Sci&Tech Co Ltd has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Guangzhou Echom Sci&Tech Co Ltd (002420)?
Our model-based price target is the fair value of ¥3.46 (as of Sep 24, 2026) from 17 valuation models. Cautious scenario ¥2.62, optimistic scenario ¥4.51. It is a calculation from audited fundamentals, not an analyst target.
What is the Guangzhou Echom Sci&Tech Co Ltd stock forecast for 2026?
Our models put fair value at ¥3.46, about −43% upside versus a price of ¥6.08 (overvalued). Cautious scenario ¥2.62, optimistic scenario ¥4.51. The calculation is refreshed regularly with new filings.
What is the revenue of Guangzhou Echom Sci&Tech Co Ltd (002420)?
Guangzhou Echom Sci&Tech Co Ltd reported trailing-twelve-month revenue of about 2.8B CNY (latest available figure, as of Sep 24, 2026).
Does Guangzhou Echom Sci&Tech Co Ltd pay a dividend?
Guangzhou Echom Sci&Tech Co Ltd currently shows a dividend yield of about 0.58% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Guangzhou Echom Sci&Tech Co Ltd (002420)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Guangzhou Echom Sci&Tech Co Ltd it is ¥3.46 per share (as of Sep 24, 2026), against a price of ¥6.08. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Guangzhou Echom Sci&Tech Co Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 002420 trades above its calculated fair value: price ¥6.08, fair value ¥3.46, a gap of about −43% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 002420?
No. The price is what the market pays today (¥6.08); the fair value is what the company's own numbers justify (¥3.46). For Guangzhou Echom Sci&Tech Co Ltd the two are ¥2.62 per share apart. That gap is exactly why we show both numbers side by side.
How much is Guangzhou Echom Sci&Tech Co Ltd worth?
The market values Guangzhou Echom Sci&Tech Co Ltd at about 2.5B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥6.08; our models calculate a fair value of ¥3.46 per share.
What do the bullish and bearish scenarios say about 002420?
Our models span a range for Guangzhou Echom Sci&Tech Co Ltd: cautious scenario ¥2.62, base ¥3.46, optimistic ¥4.51 per share (as of Sep 24, 2026, price ¥6.08). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 002420?
Guangzhou Echom Sci&Tech Co Ltd trades at a price-to-earnings ratio of 12.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥3.46 is built from several models across several years. Other multiples: P/B 3.3, P/S 0.9, EV/EBITDA 19.6.
How solid is the balance sheet of Guangzhou Echom Sci&Tech Co Ltd (002420)?
Balance-sheet figures for Guangzhou Echom Sci&Tech Co Ltd (as of Sep 24, 2026): return on equity 28.1%, debt of 0.09 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 002420 from its 52-week high?
Guangzhou Echom Sci&Tech Co Ltd trades at ¥6.08, about 31% below its 52-week high of ¥8.75 and 26% above the low of ¥4.83 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of ¥3.46 is for.
Which stocks are comparable to Guangzhou Echom Sci&Tech Co Ltd?
From the same area (Technology) we also value Samsung Electronics Co, Sony Group, Xiaomi Corporation, LG Electronics Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Guangzhou Echom Sci&Tech Co Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price ¥6.08, calculated fair value ¥3.46 (−43%), Quality Score 51/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 002420 calculated?
We run Guangzhou Echom Sci&Tech Co Ltd through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥3.46, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Guangzhou Echom Sci&Tech Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Guangzhou Echom Sci&Tech Co Ltd (002420)?
The closing price on Sep 24, 2026 was ¥6.08. Our model-based fair value is ¥3.46, about −43% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Guangzhou Echom Sci&Tech Co Ltd right now?
The price sits above even our optimistic bull case (¥4.51). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Guangzhou Echom Sci&Tech Co Ltd (002420) come from?
Earnings per share at Guangzhou Echom Sci&Tech Co Ltd grew +4.5 % a year from 2014 to 2024. Broken into its drivers: revenue per share −3.4 %, EBIT margin +28.1 %, tax rate −0.2 %, residual (interest, one-offs) −15.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Guangzhou Echom Sci&Tech Co Ltd
How large is the market capitalisation of Guangzhou Echom Sci&Tech Co Ltd (002420)?
The market capitalisation of Guangzhou Echom Sci&Tech Co Ltd is 2.5B CNY (≈ $373M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Guangzhou Echom Sci&Tech Co Ltd (002420)?
The price-to-sales ratio of Guangzhou Echom Sci&Tech Co Ltd is 0.83 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Guangzhou Echom Sci&Tech Co Ltd (002420)?
Earnings per share at Guangzhou Echom Sci&Tech Co Ltd are ¥0.4700 (price ÷ EPS = P/E 12.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Guangzhou Echom Sci&Tech Co Ltd (002420)?
The dividend yield of Guangzhou Echom Sci&Tech Co Ltd is 0.6% (payout 7.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Guangzhou Echom Sci&Tech Co Ltd (002420)?
The net margin of Guangzhou Echom Sci&Tech Co Ltd is 6.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Guangzhou Echom Sci&Tech Co Ltd (002420)?
The return on equity (ROE) of Guangzhou Echom Sci&Tech Co Ltd is 28.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Guangzhou Echom Sci&Tech Co Ltd (002420)?
On an EBIT basis the return on assets of Guangzhou Echom Sci&Tech Co Ltd is 1.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Guangzhou Echom Sci&Tech Co Ltd (002420)?
The operating margin of Guangzhou Echom Sci&Tech Co Ltd is 5.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Guangzhou Echom Sci&Tech Co Ltd (002420)?
Revenue at Guangzhou Echom Sci&Tech Co Ltd is growing −18.4% versus a year earlier (3y avg +3.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Guangzhou Echom Sci&Tech Co Ltd (002420)?
Earnings per share at Guangzhou Echom Sci&Tech Co Ltd are growing −15.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Guangzhou Echom Sci&Tech Co Ltd (002420) generate?
The free cash flow of Guangzhou Echom Sci&Tech Co Ltd is −149M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Guangzhou Echom Sci&Tech Co Ltd (002420) carry?
The net debt of Guangzhou Echom Sci&Tech Co Ltd is 302M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Guangzhou Echom Sci&Tech Co Ltd in the live analysis
One click puts Guangzhou Echom Sci&Tech Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
